Malaria control - Addressing challenges to ambitious goals

New England Journal of Medicine

Volumn 361, Issue 5, 2009, Pages 522-523

  Campbell, Carlos C ^a  

^a PATH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTEMISININ; ARTESUNATE; DIHYDROARTEMISININ; INSECTICIDE; MALARIA VACCINE; MEFLOQUINE;

AFRICA; ANTIBIOTIC SENSITIVITY; ANTIMALARIAL DRUG RESISTANCE; ANTIPROTOZOAL ACTIVITY; ASIA; BED NET; CLINICAL TRIAL; DRUG EFFICACY; DRUG TREATMENT FAILURE; EDITORIAL; ERADICATION THERAPY; HEALTH CARE COST; HEALTH PROGRAM; HUMAN; IC 50; IMMUNIZATION; MALARIA; MALARIA CONTROL; MORTALITY; NONHUMAN; PARASITE TRANSMISSION; PARASITEMIA; PLASMODIUM FALCIPARUM; PREVALENCE; PRIORITY JOURNAL; PUBLIC HEALTH PROBLEM; SPOROZOITE; VACCINE PRODUCTION;

EID: 68049133360     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMe0905159     Document Type: Editorial

References (12)

1. Steketee RW, Sipilanyambe N, Chimumbwa J, et al. National malaria control and scaling up for impact: the Zambia experience through 2006. Am J Trop Med Hyg 2008;79:45-52. (Pubitemid 351957204)
2. Bhattarai A, Ali AS, Kachur SP, et al. Impact of artemisinin-based combination therapy and insecticide-treated nets on malaria burden in Zanzibar. PLoS Med 2007;4(11):e309. (Pubitemid 350220531)
3. Global Malaria Action Plan for a malaria-free world. Geneva: Roll Back Malaria Partnership, 2009. (Accessed July 10, 2009, at http://rbm.who.int/gmap/ index.html.)
4. Malaria Eradication Research Agenda (malERA) home page. (Accessed July 10, 2009, at http://malera.tropika.net/.)
5. Dondorp AM, Nosten F, Yi P, et al. Artemisinin resistance in Plasmodium falciparum malaria. N Engl J Med 2009;361:455-467
6. Noedl H, Socheat D, Satimai W. Artemisinin-resistant malaria in Asia. N Engl J Med 2009;361:540-541
7. Maude RJ, Pontavornpinyo W, Saralamba S, et al. The last man standing is the most resistant: eliminating artemisinin-resistant malaria in Cambodia. Malar J 2009;8:31.
8. Roestenberg M, McCall M, Hopman J, et al. Protection against a malaria challenge by sporozoite inoculation. N Engl J Med 2009;361:468-477
9. Luke TC, Hoffman SL. Rationale and plans for developing a non-replicating, metabolically active, radiation-attenuated Plasmodium falciparum sporozoite vaccine. J Exp Biol 2003;206:3803-3808
10. Collins WE, Jeffery GM. A retrospective examination of secondary sporozoite- and trophozoite-induced infections with Plasmodium falciparum: development of parasitologic and clinical immunity following secondary infection. Am J Trop Med Hyg 1999;61:Suppl:20-35. (Pubitemid 29347625)
11. Hoffman SL, Goh LM, Luke TC, et al. Protection of humans against malaria by immunization with radiation attenuated Plasmodium falciparum sporozoites. J Infect Dis 2002;185:1155-1164
12. Abdulla S, Oberholzer R, Juma O, et al. Safety and immunogenicity of RTS,S/AS02D malaria vaccine in infants. N Engl J Med 2008;359:2533-2544